Responsiveness and Minimum Important Differences for the Erection Quality Scale

Journal of Urology

Volumn 178, Issue 5, 2007, Pages 2076-2081

  Rosen, Raymond C ^a,b   Wincze, John ^c   Mollen, Martin D ^d   Gondek, Kathleen ^e   McLeod, Lori D ^f   Fisher, William A ^g  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c BROWN UNIVERSITY   (United States)

^d Arizona Research Center   (United States)

^e BAYER CORPORATION   (United States)

^f RTI HEALTH SOLUTIONS   (United States)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

impotence; questionnaires; vardenafil

Indexed keywords

PLACEBO; VARDENAFIL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISCRIMINANT VALIDITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ERECTILE DYSFUNCTION; ERECTION QUALITY SCALE; FLUSHING; HEADACHE; HUMAN; IMPOTENCE; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; RACE; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SIDE EFFECT; SMOKING; STATISTICAL ANALYSIS;

DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ERECTILE DYSFUNCTION; FOLLOW-UP STUDIES; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; PATIENT SATISFACTION; PENILE ERECTION; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; QUESTIONNAIRES; SULFONES; TREATMENT OUTCOME; TRIAZINES;

EID: 35148821742     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.07.019     Document Type: Article

References (10)

1. Rosen R.C., Riley A., Wagner G., Osterloh I.H., Kirkpatrick J., and Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822
2. Cappelleri J.C., Althof S.E., Siegel R.L., Shpilsky A., Bell S.S., and Duttagupta S. Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction. Int J Impot Res 16 (2004) 30
3. Kubin M., Trudeau E., Gondek K., Seignobos E., and Fugl-Meyer A.R. Early conceptual and linguistic development of a patient and partner treatment satisfaction scale (TSS) for erectile dysfunction. Eur Urol 46 (2004) 768
4. Wincze J., Rosen R., Carson C., Korenman S., Niederberger C., Sadovsky R., et al. Erection quality scale: initial scale development and validation. Urology 64 (2004) 351
5. Fisher W.A., Rosen R.C., Mollen M., Brock G., Karlin G., Pommerville P., et al. Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med 2 (2005) 699
6. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. (1988), Lawrence Earlbaum Associates Inc, New York
7. Juniper E.F., Guyatt G.H., Willan A., and Griffith L.E. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 47 (1994) 81
8. Streiner D.L., and Norman G.R. Health Measurement Scales: A Practical Guide to Their Development and Use. 2nd ed. (1995), Oxford University Press, New York 65
9. Ringash J., O'Sullivan B., Bezjak A., and Redelmeier D. Minimal important difference for quality of life measures is about five to ten percent of the instrument range (2000) Presented at American Society of Clinical Oncology Annual Meeting, New Orleans, Louisiana, May 20-23
10. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4 (2006) 79